3-Hexenoic acid, methyl ester
Common Name: |
3-Hexenoic acid, methyl ester |
IUPAC Name: |
methyl (E)-hex-3-enoate |
Molecular Formula: |
C10H20O |
SMILES: |
CCC=CCC(=O)OC |
Inchi: |
1S/C7H12O2/c1-3-4-5-6-7(8)9-2/h4-5H,3,6H2,1-2H3/b5-4+ |
Inchi Key: |
XEAIHUDTEINXFG-SNAWJCMRSA-N |
Cas No: |
2396-78-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
156.27 |
Mass (g/mol) |
128.084 |
Molar Refractivity |
50.87 |
Net Charge |
|
HBD |
1 |
HBA |
1 |
Rt Bonds |
7 |
Rings |
|
TPSA |
20.23 |
Hetero Atoms |
2 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
168.00 to 169.00 |
Vapor Pressure (mmHg@25.00 °C) |
4.057 |
Vapor Density (Air =1) |
>1 |
Fraction Csp3 |
0.80 |
LogP |
1.516 |
iLOGP |
2.87 |
XLOGP3 |
3.29 |
WLOGP |
2.90 |
MLOGP |
2.70 |
ESOL Log S |
-2.42 |
ESOL Solubility (mg/ml) |
0.595 |
ESOL Solubility (mol/l) |
0.004 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.39 |
Ali Solubility (mg/ml) |
0.06 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.60 |
Silicos-IT Solubility (mg/ml) |
0.39 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.92 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.754 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.307 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |